Gentaur Urelumab – Anti-TNFRSF9 / CD137 Antibody

https://www.pathco.org/web/image/product.template/137748/image_1920?unique=6dd64d0
(0 review)
Targets CD137 (4-1BB), a costimulatory molecule on activated T-cells. Urelumab enhances T-cell responses and is ideal for immune activation and cancer immunotherapy research.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 €

1,234,567.00 €

Not Available For Sale

This combination does not exist.


Internal Reference: GMA-TNFRSF9
Display Name: [GMA-TNFRSF9] Gentaur Urelumab – Anti-TNFRSF9 / CD137 Antibody
Image 512: